Other outcomes considered by thistrial included ALT levels and glucagon-like peptide (GLP-1) levels and BMI changes.The insulin resistance level of both groups was also evaluated using the homeostasisevaluation model, known as homeostasis model assessment - insulin resistance(HOMA-IR), obtained by the equation: fasting insulin×fasting glucose/405 (inmg/dL). The gene discussed is INS; the disease is Insulin resistance.